There is some debate as to whether GLP-1 agonist drugs like Wegovy can lead to unhealthy muscle mass loss in addition to ...

A new study suggests that 40% of American adults have conditions that could benefit from semaglutide treatment.

The Biden administration is proposing Medicare and Medicaid coverage for glucagon-like peptide 1 receptor agonist (GLP-1 RA) ...

Clinicians are advised to screen patients for conditions that would have rendered them ineligible to participate in the ...

For people taking Ozempic, Wegovy or other GLP-1 medications, Thanksgiving may look a little different. Experts give tips on how to handle challenges and enjoy the holiday.

Millions of obese Americans would get access to popular weekly injectables that would help them shed pounds quickly if a $35 ...

Patrick Smith, President of Drug Development Solutions, Certara. Inflation and the Covid-19 pandemic have put pharmaceutical ...

Strata Decision Technology data finds the number of bariatric surgeries in the Chicago area may have fallen by more than half ...

The medications − part of a class of drugs called GLP-1, or glucagon-like peptide-1, receptor agonists − were first used to ...

The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.

Those on the medications, known as GLP-1s or glucagon-like peptide-1, will additionally weigh in four times a month on "smart ...

The cutting-edge weight-loss drug Zepbound can protect obese people from developing type 2 diabetes, a new clinical ...